Jean-Guillaume Letarouilly

Author

Université de Lille ORCID

Also Known As

J.-G. Letarouilly, J.G. Letarouilly, Jean-Guillaume Letarouilly, Letarouilly, Jean-Guillaume

Publications

534

Citations

H-Index

Concepts

All Affiliations

Université de Lille Hôpital Saint-Philibert Centre Hospitalier Universitaire de Lille Inserm Assistance Publique – Hôpitaux de Paris

About

Jean-Guillaume Letarouilly is an author at Université de Lille specializing in medicine, rheumatoid arthritis, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	86
2	Orthopaedics	2	2	58
3	Health Sciences	1	1	28
4	Cell Biology	1	1	28
5	Metabolism	1	1	28

Jean-Guillaume Letarouilly

Publications

145

Citations

H-Index

Page 1

	Year	Citations
Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study Cécile Philippoteaux, Thibaut Delépine, Émeline Cailliau, Joint Bone Spine RheumatologySpondyloarthritisDifficult-to-treat Axial SpondyloarthritisChronic Musculoskeletal ConditionSurgery	2023	30
Adipocyte-induced transdifferentiation of osteoblasts and its potential role in age-related bone loss Aline Clabaut, Céline Grare, Gaëlle Rolland-Valognes, PLoS ONE Microarray Gene ExpressionGeneticsOsteoporosisEpigeneticsOrthopaedic Surgery	2021	28
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis Cécile Philippoteaux, A. Marty-Ane, Émeline Cailliau, Seminars in Arthritis and Rheumatism Rheumatoid DisorderRheumatologyMedicineRheumatic DiseasesOsteoarthritis	2023	28
Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis Julien Damart, Georgios Filippou, Mariano Andrés, Lara D. Veeken	2023	17
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison Jean-Guillaume Letarouilly, B. Flachaire, Céline Labadie, Lara D. Veeken	2020	16
Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings Cécile Philippoteaux, V. Deprez, Aurore Nottez, Journal of Clinical Medicine	2022	14
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case–control MISSIL study Jean-Guillaume Letarouilly, Thao Pham, Adeline Piérache, Lara D. Veeken	2021	12

Page 1